“Evidence linking inflammatory mechanisms to cardiovascular diseases, such as atherosclerosis and hypertension,
continues to build. However, the identity of the
precise inflammatory mediators and the mechanisms that
underlie their cardiovascular actions remain unclear. The
cytokineinterleukin 6 (IL-6) is released from vascular tissue
in response to angiotensin II (Ang II), and our laboratory
showed that acute, stress-induced hypertension, which is Ang
II dependent, is attenuated in IL-6 knockout (KO) mice....
The goal of this study was to determine whether an effect
of IL-6 on Ang II–mediated renal vasoconstriction could be a
potential mechanism for the dependence of Ang II hypertension
on IL-6. … We used chronically implanted renal artery
flow probes to test the hypothesis that chronic Ang II–
induced renal vasoconstriction would be attenuated in IL-6
KO mice.”
Hypertension published an editorial accompanying Banes-Berceli’s paper. The author Michael Ryan writes
“In this
issue of Hypertension, Brands et al take an important step in
the direction of understanding the mechanism by which IL-6
contributes to Ang II hypertension. Similar to their initial
work, blood pressure in the current study was lower in IL-6
knockout mice given Ang II. However, different from results
obtained in the former study, the hypertension was completely
abolished rather than only blunted. This is most likely
because the animals from the former study were maintained
on a high-salt diet, in addition to the Ang II. The reason that
Ang II is able to increase pressure in IL-6 knockout mice
maintained on a high-salt diet is not clear but suggests that
some permissive factors or alternative pathways are present
during high-salt intake….
The major advance made in the present study comes from
data collected during chronic measurements of renal blood
flow (RBF) in conscious mice. These results show that Ang II
dose-dependently produces a sustained decrease in RBF in
wild-type mice. Surprisingly, the RBF response to Ang II in
IL-6 knockout mice was similar to the wild-type mice, even
as the wild-type animals exhibited the expected hypertension
that was otherwise absent in the IL-6 knockout mice. The
authors go further to show that afferent arteriolar constriction
in response to Ang II is the same between wild-type and IL-6
knockout mice, at least under control conditions. These data
are provocative because they raise perhaps as many questions
as are answered related to the role that IL-6 plays in Ang II
hypertension.”
Banes-Berceli’s laboratory is currently funded by a grant from the National Institutes of Health. Hind Al-Azawi is a graduate student in the Master of Science program in biology. She was also an undergraduate at OU, was a Summer Undergraduate Research Fellow, and has presented her results at the Meeting of Minds and at an International Experimental Biology Meeting in Anahiem, California.
CBR member Amy Banes-Berceli recently published a study of hypertension using genetically engineered knock-out mice.
Created by Brad Roth (roth@oakland.edu) on Sunday, January 9, 2011 Modified by Brad Roth (roth@oakland.edu) on Monday, January 10, 2011 Article Start Date: Sunday, January 9, 2011